Literature DB >> 10901717

Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.

M D Davis1, B S Gostout, R M McGovern, D H Persing, R L Schut, M R Pittelkow.   

Abstract

Warts can be difficult to diagnose and to treat in the setting of human immunodeficiency virus (HIV) infection. A 37-year-old woman with a background of HIV presented with a large verrucous plaque involving her right foot. Human papillomavirus (HPV)-66 was identified in the lesional skin biopsy sample and in scrapings obtained from her cervix. The wart rapidly responded to topical cidofovir therapy. HPV-66 is a novel HPV type to be associated with verruca vulgaris. Topical cidofovir should be further investigated as an alternative treatment modality for verruca vulgaris.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901717     DOI: 10.1067/mjd.2000.100534

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Topical vitamin A treatment of recalcitrant common warts.

Authors:  Anca Gaston; Robert F Garry
Journal:  Virol J       Date:  2012-01-17       Impact factor: 4.099

Review 2.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 3.  Dermatologic manifestations of HPV in HIV-infected individuals.

Authors:  Rachel H Gormley; Carrie L Kovarik
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

4.  Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.

Authors:  Neil D Christensen; Nancy M Cladel; Jiafen Hu; Karla K Balogh
Journal:  Antiviral Res       Date:  2014-06-16       Impact factor: 5.970

5.  Implication of human papillomavirus-66 in vulvar carcinoma: a case report.

Authors:  Ioannis C Kotsopoulos; Georgios P Tampakoudis; Dimitrios G Evaggelinos; Anastasia I Nikolaidou; Panagiota A Fytili; Vasilios C Kartsiounis; Domniki K Gerasimidou
Journal:  J Med Case Rep       Date:  2011-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.